EQUITY RESEARCH 
 
Page | 1 | PHILLIPCAPITAL HONGKONG RESEARCH 
上海機場 (600009 CH) 
整體上市方案確認，業績拐點臨近 
 
中國 | 航空支援 | 滬港通  
 
 
 
3 March 2022 
 
 
投資概要 
2021 年回顧 
在疫情影響下，2021 年中國境內機場運送旅客輸送量達到9.07 億人次，比2020 年增
長了5.9%，恢復到了2019 年的67.1%，即相對於2019 年下滑32.9%。分市場來看，
受春運政策和國內零星疫情反復的影響，國內航線的航空需求低點出現在2/8/11 月，
高點在3/4/5/7 月，；而受民航局嚴控海外疫情輸入，國際/地區航班量始終處於低
谷，全年波動較小，相比2019 年，月度的國際/地區航班量均下跌超90%，僅4/7 月
航班量同比2020 年有小幅增長。 
上海機場2021 年全年完成旅客輸送量為3221 萬人次，同比提高5.7%，略微弱於行業
整體的5.9%，相比2019 年則大幅下降57.7%。其中，國內線旅客輸送量3053 萬人
次，同比提高19.2%，相比2019 年下降18.9%，國際及地區線旅客輸送量167.9 萬人
次，同比下降65.5%，相比2019 年下降95.6%。丌過，受旺盛的貨運需求拉動，公司
2021 實現年貨郵輸送量約399 萬噸，較20 年同期增長8.1%，較19 年同期增長
9.7%。 
相對於國內其他機場，上海浦東機場業績更依賴國際航線以及免稅業務租金等非航收
入，因此國際客運大幅下降對機場業績的衝擊較大。公司於1 月24 日發佈業績預告
稱，預計2021 年虧損16.4 億元-17.8 億元人民幣，對應單季虧損分別為4.36 億/3.04
億/5.1 億/3.9-5.4 億，預計全年免稅收入接近5 億元，與2019 年的接近50 億元相比縮
水近九成。 
 
 
2021 年中國機場國內出港航班量及同比增速(vs2020/2019) 
 
Source: VariFlight, Phillip Securities Group 
 
 
 
增持 （下調） 
 
現價 RMB 54.16 
(現價截至3 月1 日) 
目標價 RMB 62.3 (+15%) 
 
公司資料 
普通股股東 (百萬股) : 
1927 
市值 (人幣百萬元) : 
104364 
52 周 最高價/最低價 (人民幣元) : 
64.29/36.6 
 
 
 
 
主要股東 % 
上海機場(集團)有限公司 
46.25 
香港中央結算有限公司 
18.37 
 
 
 
股價 & 上證指數 
 
Source: aastock, Phillip Securities (HK) Research 
 
財務資料 
CNY mn 
FY20 
FY21E 
FY22E 
FY23E 
Net Sales 
4303 
3772 
6484 
9753 
Net Profit 
-1274 
-1687 
642 
2235 
EPS, CNY 
-0.66 
-0.88 
0.33 
1.16 
P/E, x 
NA 
NA 
162.5 
46.7 
BVPS, CNY 
15.16 
14.28 
14.61 
15.69 
P/BV, x 
3.6 
3.8 
3.7 
3.5 
DPS (CNY) 
0.00 
0.00 
0.09 
0.41 
Div. Yield (%) 
0.0% 
0.0% 
0.2% 
0.8% 
Source: Company reports, Phillip Securities Est. 
 
研究員 
章晶 (+ 86 021-51699400-103) 
zhangjing@phillip.com.cn 
 
 
 
Page | 2 | PHILLIPCAPITAL HONGKONG RESEARCH 
SIA CH 
UPDATE REPORT 
 
 
2021 年中國機場國際/地區出港航班量及同比增速(vs2020/2019) 
 
Source: VariFlight, Phillip Securities Group 
 
2022 年初延續溫和恢復態勢 
丌過隨著國內疫情好轉和出行管控放鬆，國內航空需求整體呈現出較強的韌性
和迅速恢復的趨勢。2022 年1 月份，中國境內機場客運航班起降599476 架次，
同比21 年上升1.7%，環比12 月份增長11.78%，相比19 年1 月下降25.28%；
其中，國內航班恢復程度較上月提升，環比12 月增長了11.84%，同比2021 年
上升0.66%，相比2019 年下降了17.46%；但國際/地區航班環比12 月份增長了
4.28%，同比2021 年下降了41.66%，相比2019 年下降95.07%，仍沒有明顯恢
復跡象。 
根據上海機場的公告，其1 月飛機起降29,735 架次，同比增長13.99%；旅客輸
送量211.83 萬人次，同比增長14.47%；實現貨郵輸送量31.87 萬噸，同比下降
10.43%。 
近日政府公佈民航十四五規劃，其中將2021~2022 年定義為中國民航業的恢復
期和積蓄期，而2023~2025 年是增長期和釋放期，重點將擴大國內市場和恢復
國際市場，並大力發展貨運市場，我們預計2022 年有望成為機場類公司的業績
拐點，而2023 年起將開啟業績反彈。 
 
191 億資產注入整體上市方案確認 
根據公告，上海機場與控股股東機場集團簽署協定，將標的資產虹橋機場100%
股權交易作價約為145 億元、物流公司100%股權交易作價約為31 億元、浦東
機場第四跑道交易作價約為15 億元，合計約為191 億元，上市公司預計將向機
場集團發行股份約4.34 億股，發行價格為44.09 元/股。同時公司向機場集團定
向增發丌超過約1.28 億股，配套融資規模下調至丌超過50 億元，發行價格為
39.19 元/股，募集資金擬用於公司四型機場建設項目、智慧貨站項目、智慧物
流園區綜合提升專案及補充流動資金。交易完成後機場集團持有上市公司總股
本的58.38%（交易前為46.25%）。 
我們認為，主營國內線路的虹橋機場業務復蘇相對較快，注入上市公司將實現
航線資源重新整合和優化，長期來看將具有良好的發展前景和較強盈利能力。
 
 
Page | 3 | PHILLIPCAPITAL HONGKONG RESEARCH 
SIA CH 
UPDATE REPORT 
受疫情影響，以國際航線為主的浦東機場運營成本較高，為了更加合理高效地
利用資源，上海機場已嘗試將大量閒置的國際時刻資源轉而優先投向國內市
場，令浦東機場客流更快回暖。另外，此次重組還將置入物流貨運業務，有助
於完善航空貨運樞紐網路、拓展多式聯運，優化上海兩場的貨運佈局。 
 
投資建議 
我們認為隨著疫苗接種率的提高，雖然過程仍會遇到遭遇挑戰和波折，復蘇之
路已然清晰，被疫情拖累的機場渡過最黑暗時期後即將迎來曙光，未來上海機
場的免稅價值將會重新回歸，公司的業績彈性較大。由於增發資產注入尚未完
成，暫丌考慮相關影響。我們調整上海機場2021/2022/2023 年的每股EBITDA 預
測值，相應的向上調整目標價至人民幣62.3 元（原為56.3 元），分別對應
NA/45.8/29.2 倍的估值倍數，“增持”評級。(現價截至3 月1 日) 
 
 
 
 
Page | 4 | PHILLIPCAPITAL HONGKONG RESEARCH 
SIA CH 
UPDATE REPORT 
 
 
財務資料 
 
 
(現價截至3 月1 日) 
 
 
Page | 5 | PHILLIPCAPITAL HONGKONG RESEARCH 
SIA CH 
UPDATE REPORT 
 
PHILLIP RESEARCH STOCK SELECTION SYSTEMS 
 
We do not base our recommendations entirely on the above quantitative return bands.  We consider qualitative factors like (but not limited to) a 
stock's risk reward profile, market sentiment, recent rate of share price appreciation, presence or absence of stock price catalysts, and speculative 
undertones surrounding the stock, before making our final recommendation 
 
GENERAL DISCLAIMER 
This publication is prepared by Phillip Securities (Hong Kong) Ltd (“Phillip Securities”). By receiving or reading this publication, you agree to be bound by the terms and 
limitations set out below.  
 
This publication shall not be reproduced in whole or in part, distributed or published by you for any purpose. Phillip Securities shall not be liable for any direct or 
consequential loss arising from any use of material contained in this publication.  
 
The information contained in this publication has been obtained from public sources which Phillip Securities has no reason to believe are unreliable and any analysis, 
forecasts, projections, expectations and opinions (collectively the “Research”) contained in this publication are based on such information and are expressions of belief 
only. Phillip Securities has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, 
complete or verified or should be relied upon as such. Any such information or Research contained in this publication is subject to change, and Phillip Securities shall not 
have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will 
Phillip Securities be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made 
available, even if it has been advised of the possibility of such damages.  
 
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this material are as of the date indicated and are subject to change at any time 
without prior notice.  
 
This material is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any 
particular person. The products mentioned in this material may not be suitable for all investors and a person receiving or reading this material should seek advice from a 
financial adviser regarding the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, 
before making a commitment to invest in any of such products. 
This publication should not be relied upon as authoritative without further being subject to the recipient’s own independent verification and exercise of judgment. The 
fact that this publication has been made available constitutes neither a recommendation to enter into a particular transaction nor a representation that any product 
described in this material is suitable or appropriate for the recipient. Recipients should be aware that many of the products which may be described in this publication 
involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made unless all 
such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein 
with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.  
 
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of a security. Any decision to purchase securities mentioned in this research 
should take into account existing public information, including any registered prospectus in respect of such security. 
 
Disclosure of Interest 
Analyst Disclosure: Neither the analyst(s) preparing this report nor his associate has any financial interest in or serves as an officer of the listed corporation covered in 
this report. 
Firm’s Disclosure: Phillip Securities does not have any investment banking relationship with the listed corporation covered in this report nor any financial interest of 1% or 
more of the market capitalization in the listed corporation. In addition, no executive staff of Phillip Securities serves as an officer of the listed corporation. 
 
Availability 
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where 
such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities to any registration or 
licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction. 
 
Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited (“PSHK”) believed to be accurate. PSHK does not bear responsibility for any 
loss occasioned by reliance placed upon the contents hereof.  PSHK (or its affiliates or employees) may have positions in relevant investment products. For details of 
different product's risks, please visit the Risk Disclosures Statement on http://www.phillip.com.hk.   
©  
2022 Phillip Securities (Hong Kong) Limited 
Total Return 
Recommendation 
Rating 
Remarks 
>+20% 
Buy 
1 
>20% upside from the current price 
+5% to +20% 
Accumulate 
2 
+5% to +20%upside from the current price 
-5% to +5% 
Neutral 
3 
Trade within  ± 5% from the current price 
-5% to -20% 
Reduce 
4 
-5% to -20% downside from the current price 
<-20% 
Sell 
5 
>20%downside from the current price 
 
 
Page | 6 | PHILLIPCAPITAL HONGKONG RESEARCH 
COMPANY NAME INITIATING COVERAGE 
 
 
Contact Information (Regional Member Companies) 
 
SINGAPORE 
Phillip Securities Pte Ltd 
250 North Bridge Road, #06-00 Raffles City Tower, 
Singapore 179101 
Tel : (65) 6533 6001 Fax: (65) 6535 3834 
www.phillip.com.sg 
MALAYSIA 
Phillip Capital Management Sdn Bhd 
B-3-6 Block B Level 3, Megan Avenue II, 
No. 12, Jalan Yap Kwan Seng, 50450 Kuala Lumpur 
Tel (60) 3 2162 8841 Fax (60) 3 2166 5099 
www.poems.com.my 
JAPAN 
Phillip Securities Japan, Ltd 
4-2 Nihonbashi Kabutocho, Chuo-ku 
Tokyo 103-0026 
Tel: (81) 3 3666 2101 Fax: (81) 3 3664 0141 
www.phillip.co.jp 
INDONESIA  
PT Phillip Securities Indonesia 
ANZ Tower Level 23B, Jl Jend Sudirman Kav 33A, 
Jakarta 10220, Indonesia 
Tel (62) 21 5790 0800 Fax: (62) 21 5790 0809 
www.phillip.co.id 
CHINA  
Phillip Financial Advisory (Shanghai) Co. Ltd.  
No 436 Heng Feng Road, Green Tech Tower Unit 604 
Shanghai 200 070 
Tel (86) 21 5169 9400 Fax: (86) 21 6091 1155 
www.phillip.com.cn 
INDIA  
PhillipCapital (India) Private Limited 
No. 1, 18th Floor, Urmi Estate, 95 Ganpatrao Kadam Marg, 
Lower Parel West, Mumbai 400013 
Tel: (9122) 2300 2999 Fax: (9122) 6667 9955 
www.phillipcapital.in 
THAILAND 
Phillip Securities (Thailand) Public Co. Ltd. 
15th Floor, Vorawat Building,  849 Silom Road, 
Silom, Bangrak, Bangkok 10500 Thailand 
Tel (66) 2 2268 0999  Fax: (66) 2 2268 0921 
www.phillip.co.th 
FRANCE 
King & Shaxson Capital Ltd. 
3rd Floor, 35 Rue de la Bienfaisance  
75008 Paris France 
Tel (33) 1 4563 3100 Fax : (33) 1 4563 6017 
www.kingandshaxson.com 
UNITED KINGDOM  
King & Shaxson Ltd. 
6th Floor, Candlewick House, 120 Cannon Street 
London, EC4N 6AS 
Tel (44) 20 7929 5300 Fax: (44) 20 7283 6835 
www.kingandshaxson.com 
UNITED STATES 
Phillip Futures Inc. 
141 W Jackson Blvd Ste 3050 
The Chicago Board of Trade Building 
Chicago, IL 60604 USA 
Tel (1) 312 356 9000 Fax: (1) 312 356 9005 
AUSTRALIA  
PhillipCapital Australia 
Level 10, 330 Collins Street 
Melbourne VIC 3000  
Tel (+61) 3 8633 9803 Fax (+61) 3 8633 9899 
www.phillipcapital.com.au 
SRI LANKA  
Asha Phillip Securities Limited 
Level 4, Millennium House, 46/58 Navam Mawatha, 
Colombo 2, Sri Lanka 
Tel: (94) 11  2429 100 Fax: (94) 11 2429 199 
www.ashaphillip.net/home.htm 
HONG KONG  
Phillip Securities (HK) Ltd 
11/F United Centre 95 Queensway Hong Kong 
Tel (852) 2277 6600 Fax: (852) 2868 5307 
www.phillip.com.hk 
 
 
 
